汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可

智通财经2025-05-09

智通财经APP讯，汇宇制药(688553.SH)发布公告，公司子公司Seacross Pharma(Europe)Ltd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2534178032?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-09 16:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534178032","market":"us","top_or_hot":-1,"title":"汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可","media":"智通财经","content":"<div>\n<p>智通财经APP讯，汇宇制药(688553.SH)发布公告，公司子公司Seacross Pharma(Europe)Ltd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1291338.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-09 16:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1291338.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，汇宇制药(688553.SH)发布公告，公司子公司Seacross Pharma(Europe)Ltd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1291338.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688553","symbol_name":"汇宇制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1291338.html","article_id":"2534178032","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534178032","pubTimestamp":1746779991,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，汇宇制药 发布公告，公司子公司Seacross PharmaLtd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作、肌肉抽搐性发作、强直-阵挛性发作，以及局灶性和继发性全身性发作。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688553":"汇宇制药","BK0239":"医药制造"},"translate_title":"Two products of Huiyu Pharmaceutical (688553. SH) subsidiaries obtained marketing authorizations in France and Spain respectively","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688553":1},"content_text":"智通财经APP讯，汇宇制药(688553.SH)发布公告，公司子公司Seacross Pharma(Europe)Ltd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作、肌肉抽搐性发作、强直-阵挛性发作，以及局灶性和继发性全身性发作。注射用环磷酰胺是一种肿瘤药，主要用于治疗慢性淋巴细胞白血病(CLL);急性淋巴细胞白血病(ALL);作为骨髓移植的条件，联合全身照射或白消安治疗急性淋巴细胞白血病、慢性淋巴细胞白血病和急性髓系白血病;霍奇金淋巴瘤、 非霍奇金淋巴瘤和多发性骨髓瘤;转移性卵巢癌和乳腺癌;乳腺癌的辅助治疗;尤文氏肉瘤;小细胞肺癌;晚期或转移性神经母细胞瘤;危及生命的自身免疫性疾病：严重进行性狼疮肾炎和韦格纳肉芽肿病。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534178032","isCrawlerRequest":true}